Gerber recalls baby teething sticks over possible choking hazard

Arlington, Virginia — A baby food maker is recalling edible sticks meant to ease teething pain over a possible choking hazard. 

Gerber announced Friday that it was recalling and discontinuing its brand of “Sooth N Chew” teething sticks after receiving customer complaints about choking. The company said one emergency room visit had been reported. 

The teething sticks are edible teethers marketed to parents and guardians of children six months and older. They come in strawberry-apple and banana flavors. 

Gerber said it was working with the U.S. Food and Drug Administration on the recall. 

Customers who bought the teething sticks should return them to stores where they were purchased for a refund, the company said. 

Anyone concerned about an injury or illness should contact a health care provider. For any additional support needed, Gerber is available 24/7 at 1-800-4-GERBER (1-800-443-7237). 

The company says it is working with the U.S. FDA on this recall and will cooperate with them fully. 

Japan launches navigation satellite on new flagship rocket  

TOKYO — Japan’s space agency said Sunday it successfully launched a navigation satellite on its new flagship H3 rocket as the country seeks to have a more precise location positioning system of its own. 

The H3 rocket carrying the Michibiki 6 satellite lifted off from the Tanegashima Space Center on a southwestern Japanese island. 

Everything went smoothly and the satellite successfully separated from the rocket as planned about 29 minutes after the liftoff, said Makoto Arita, H3 project manager for the Japan Aerospace Exploration Agency, or JAXA. 

Officials said it is expected to reach its targeted geospatial orbit in about two weeks. 

Japan currently has the quasi-zenith satellite system, or QZSS, with four satellites for a regional navigation system that first went into operation in 2018. The Michibiki 6 will be the fifth of its network. 

Michibiki’s signals are used to supplement American GPS and will further improve positioning data for smartphones, car and maritime navigation and drones. 

Japan plans to launch two more navigation satellites to have a seven-satellite system by March 2026 to have a more precise global positioning capability without relying on foreign services, including the U.S., according to the Japan Science and Technology Agency. By the late 2030s, Japan plans to have an 11-satellite network. 

Sunday’s launch, delayed by a day due to the weather, was the fourth consecutive successful flight for the H3 system after a shocking failed debut attempt last year when the rocket had to be destroyed with its payload. 

Japan sees a stable, commercially competitive space transport capability as key to its space program and national security and has been developing two new flagship rockets as successors to the mainstay H2A series — the larger H3 and a much smaller Epsilon system. It hopes to cater to diverse customer needs and improve its position in the growing satellite launch market. 

 

US says life-saving HIV treatment can continue during aid pause

WASHINGTON — The U.S. State Department said Saturday that the President’s Emergency Plan for AIDS Relief (PEPFAR) — the world’s leading HIV initiative — was covered by a waiver for life-saving humanitarian assistance during a 90-day pause in foreign aid.

Just hours after taking office on Jan. 20, President Donald Trump ordered the pause so foreign aid contributions could be reviewed to see if they align with his “America First” foreign policy. The U.S. is the world’s largest aid donor.

Secretary of State Marco Rubio initially issued a waiver for emergency food aid and then Tuesday for life-saving medicine, medical services, food, shelter and subsistence help. However, the lack of detail in Trump’s order and the ensuing waivers has left aid groups confused as to whether their work can continue.

So, Saturday the State Department’s Bureau of Global Health Security and Diplomacy issued a memo, seen by Reuters, clarifying that PEPFAR was covered by the Jan. 28 memo and spelling out what activities were allowed.

These include life-saving HIV care and treatment services, including testing and counseling, prevention and treatment of infections including tuberculosis (TB), laboratory services, and procurement and supply chain for commodities/medicines. It also allows prevention of mother-to-child transmission services.

“Any other activities not specifically mentioned in this guidance may not be resumed without express approval,” it said.

More than 20 million people living with HIV, who represent two-thirds of all people living with the disease receiving treatment globally, are directly supported by PEPFAR.

Under Trump’s foreign aid pause, all payments by U.S. Agency for International Development (USAID) stopped Tuesday — for the first time since the fiscal year began on Oct. 1 — and have not resumed, according to U.S. Treasury data. On Monday USAID paid out $8 million and last week a total of $545 million.

The Trump administration is also moving to strip a slimmed-down USAID of its independence and put it under State Department control, two sources familiar with the discussions said Friday, in what would be a significant overhaul of how Washington allocates U.S. foreign aid. 

Mushers, dogs braved Alaska winter to deliver lifesaving serum 100 years ago

ANCHORAGE, ALASKA — The Alaska Gold Rush town of Nome faced a bleak winter. It was hundreds of miles from anywhere, cut off by the frozen sea and unrelenting blizzards, and under siege from a contagious disease known as the “strangling angel” for the way it suffocated children. 

Now, 100 years later, Nome is remembering its saviors — the sled dogs and mushers who raced for more than five days through hypothermia, frostbite, gale-force winds and blinding whiteouts to deliver lifesaving serum and free the community from the grip of diphtheria. 

Among the events celebrating the centennial of the 1925 “Great Race of Mercy” are lectures, a dog-food drive and a reenactment of the final leg of the relay, all organized by the Nome Kennel Club. 

Alaskans honor ‘heroic effort’ 

“There’s a lot of fluff around celebrations like this, but we wanted to remember the mushers and their dogs who have been at the center of this heroic effort and … spotlight mushing as a still-viable thing for the state of Alaska,” said Diana Haecker, a kennel club board member and co-owner of Alaska’s oldest newspaper, The Nome Nugget. 

“People just dropped whatever they were doing,” she said. “These mushers got their teams ready and went, even though it was really cold and challenging conditions on the trail.” 

Other communities are also marking the anniversary — including the village of Nenana, where the relay began, and Cleveland, Ohio, where the serum run’s most famous participant, a husky mix named Balto, is stuffed and displayed at a museum. 

Jonathan Hayes, a Maine resident who has been working to preserve the genetic line of sled dogs driven on the run by famed musher Leonhard Seppala, is recreating the trip. Hayes left Nenana on Monday with 16 Seppala Siberian sled dogs, registered descendants of Seppala’s team. 

A race to save lives

Diphtheria is an airborne disease that causes a thick, suffocating film on the back of the throat; it was once a leading cause of death for children. The antitoxin used to treat it was developed in 1890, and a vaccine in 1923; it is now exceedingly rare in the U.S. 

Nome, western Alaska’s largest community, had about 1,400 residents a century ago. Its most recent supply ship had arrived the previous fall, before the Bering Sea froze, without any doses of the antitoxin. Those the local doctor, Curtis Welch, had were outdated, but he wasn’t worried. He hadn’t seen a case of diphtheria in the 18 years he had practiced in the area. 

Within months, that changed. In a telegram, Welch pleaded with the U.S. Public Health Service to send serum: “An epidemic of diphtheria is almost inevitable here.” 

The first death was a 3-year-old boy on January 20, 1925, followed the next day by a 7-year-old girl. By the end of the month, there were more than 20 confirmed cases. The city was placed under quarantine. 

West Coast hospitals had antitoxin doses, but it would take time to get them to Seattle, Washington, and then onto a ship for Seward, Alaska, an ice-free port south of Anchorage, Alaska. In the meantime, enough for 30 people was found at an Anchorage hospital. 

It still had to get to Nome. Airplanes with open-air cockpits were ruled out as unsuited for the weather. There were no roads or trains that reached Nome. 

Instead, officials shipped the serum by rail to Nenana in interior Alaska, some 1,086 kilometers (675 miles) from Nome via the frozen Yukon River and mail trails. 

Thanks to Alaska’s new telegraph lines and the spread of radio, the nation followed along, captivated, as 20 mushers — many of them Alaska Natives — with more than 150 dogs relayed the serum to Nome. They battled deep snow, whiteouts so severe they couldn’t see the dogs in front of them, and life-threatening temperatures that plunged at times to minus minus 51 degrees Celsius (60 degrees Fahrenheit).

The antitoxin was transported in glass vials covered with padded quilts. Not a single vial broke. 

Seppala, a Norwegian settler, left from Nome to meet the supply near the halfway point and begin the journey back. His team, led by his dog Togo, traveled more than 320 kilometers (250 miles) of the relay, including a treacherous stretch across frozen Norton Sound. 

After about 5 1/2 days, the serum reached its destination on February 2, 1925. A banner front-page headline in the San Francisco Chronicle proclaimed “Dogs victors over blizzard in battle to succor stricken Nome.” 

The official record listed five deaths and 29 illnesses. It’s likely the toll was higher; Alaska Natives were not accurately tracked. 

Balto gains fame 

Seppala and Togo missed the limelight that went to his assistant, Gunnar Kaasen, who drove the dog team led by Balto into Nome. Balto was another of Seppala’s dogs, but was used to only haul freight after he was deemed too slow to be on a competitive team.

Balto was immortalized in movies and with statues in New York’s Central Park and one in Anchorage intended as a tribute to all sled dogs. He received a bone-shaped key to the city of Los Angeles, where legendary movie actress Mary Pickford placed a wreath around his neck. 

But he and several team members were eventually sold and kept in squalid conditions at a dime museum in Los Angeles. After learning of their plight, an Ohio businessman spearheaded an effort to raise money to bring them to Cleveland, a city in Ohio. After dying in 1933, Balto was mounted and placed on display at the Cleveland Museum of Natural History. 

Iditarod pays homage to run 

Today, the most famous mushing event in the world is the Iditarod Trail Sled Dog Race, which is not based on the serum run but on the Iditarod Trail, a supply route from Seward to Nome. Iditarod organizers are nevertheless marking the serum run’s centennial with a series of articles on its website and by selling replicas of the medallions each serum run musher received a century ago, race spokesperson Shannon Noonan said in an email. This year’s Iditarod starts March 1. 

“The Serum Run demonstrated the critical role sled dogs played in the survival and communication of remote Alaskan communities, while the Iditarod has evolved into a celebration of that tradition and Alaska’s pioneering spirit,” Noonan said. 

RFK Jr. vows to stop collecting from vaccine lawsuit if confirmed to Cabinet

WASHINGTON — Facing intense scrutiny from U.S. senators over his potential profit from vaccine lawsuits while serving as the nation’s health secretary, Robert F. Kennedy Jr. said that if he is confirmed he will not collect fees from litigation against the drugmakers of a cervical cancer vaccine.

Kennedy, who’s President Donald Trump’s pick to lead the U.S. Health and Human Services agency, told the Senate finance committee that he would amend his ethics disclosure after several senators, including Democrat Elizabeth Warren of Massachusetts, and his cousin Caroline Kennedy raised concerns about his financial arrangement with the law firm representing patients who are claiming injuries from the vaccines.

“An amendment to my Ethics Agreement is in process, and it provides that I will divest my interest in this litigation,” Kennedy said in a written response to the committee.

Initially, Kennedy had told the committee that he would continue to accept referral fees in legal cases that don’t involve the U.S. government. That included an arrangement with a law firm that’s sued Merck over Gardasil, its human papillomavirus vaccine that prevents cervical cancer. The deal earned Kennedy $850,000 last year, and he told senators he had referred hundreds of clients to the firm.

During Wednesday’s hearing, Warren outlined several ways in which Kennedy could make it easier to sue vaccine manufacturers.

“Kennedy can kill off access to vaccines and make millions of dollars while he does it,” Warren said. “Kids might die, but Robert Kennedy can keep cashing in.”

The issue also may have been a concern for Senator Bill Cassidy, a Louisiana Republican who is also a physician and is conflicted over his vote on Kennedy’s confirmation because of Kennedy’s anti-vaccine views.

The Republican president’s nominee is “financially vested in finding fault with vaccines,” Cassidy, the chair of the health committee, noted as he ended Thursday’s confirmation hearing.

Kennedy also stopped short of making other commitments, refusing to promise that he would not engage in lobbying Health and Human Services after his term ends.

Kennedy and his supporters have railed against that sort of activity, saying the “revolving door” of Washington — where federal officials trade public service jobs to influence government agencies while in the private sector — has undermined the U.S. public health system. He has criticized the practice at least a half-dozen times in social media posts over recent years.

Kennedy, who ran for president last year before dropping his bid and endorsing Trump, vowed in one post on social media platform X to “rein in lobbyists and slam shut the revolving door,” if elected president.

He first challenged President Joe Biden for the 2024 Democratic presidential nomination but then ran as an independent before striking a deal to endorse Trump in exchange for a promise to serve in a health policy role during a second Trump administration.

Now, after two days of hearings, his shot at that job is on the line with concerns about his anti-vaccine advocacy prompting nearly all Democrats to reject his nomination and a handful of Republicans who are at least considering doing the same.

If Democrats unanimously oppose Kennedy, he’ll need support from all but three Republicans. The Senate finance committee is expected to decide if he makes it to the Senate floor for a vote next week.

Kennedy’s response to the Senate committee was first reported by The New York Times.

FDA approves painkiller designed to eliminate risk of addiction

WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

It’s the first new pharmaceutical approach to treating pain in more than 20 years, offering an alternative to both opioids and over-the-counter medications like ibuprofen and acetaminophen. But the medication’s modest effectiveness and lengthy development process underscore the challenges of finding new ways to manage pain.

Studies in more than 870 patients with acute pain because of foot and abdominal surgeries showed Vertex’s drug provided more relief than a dummy pill but didn’t outperform a common opioid-acetaminophen combination pill.

“It’s not a slam dunk on effectiveness,” said Michael Schuh of the Mayo Clinic, a pharmacist and pain medicine expert who was not involved in the research. “But it is a slam dunk in that it’s a very different pathway and mechanism of action. So, I think that shows a lot of promise.”

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids, which are often available as generics for $1 or less.

Vertex began researching the drug in the 2000s, when overdoses were rocketing upward, principally driven by mass prescribing of opioid painkillers for common ailments like arthritis and back pain. Prescriptions have fallen sharply in the last decade and the current wave of the opioid epidemic is mainly due to illicit fentanyl, not pharmaceutical medicines.

Opioids reduce pain by binding to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to opioids’ addictive effects.

Vertex’s drug works differently, blocking proteins that trigger pain signals that are later sent to the brain.

“In trying to develop medicines that don’t have the addictive risks of opioid medicines, a key factor is working to block pain signaling before it gets to the brain,” Vertex’s Dr. David Altshuler, told The Associated Press last year.

Commonly reported side effects with the drug were nausea, constipation, itching, rash and headache.

“The new medication has side effect profiles that are inherently, not only different, but don’t involve the risk of substance abuse and other key side effects associated with opioids,” said Dr. Charles Argoff of the Albany Medical Center, who consulted for Vertex on the drug’s development.

The initial concept to focus on pain-signaling proteins came out of research involving people with a rare hereditary condition that causes insensitivity to pain.

Republican senator airs concerns about supporting RFK Jr to be US health secretary

WASHINGTON — A key Republican senator on Thursday said he was struggling with Robert F. Kennedy Jr.’s nomination by President Donald Trump to run the top U.S. health agency, saying he had reservations about the nominee’s “misleading arguments” on vaccines.   

“Your past of undermining confidence in vaccines with unfounded or misleading arguments concerns me,” Republican Senator Bill Cassidy, a physician from Louisiana, told Kennedy. 

“I have been struggling with the nomination,” he said at the end of Thursday’s Senate health committee hearing to consider Kennedy to run the massive Department of Health and Human Services. 

“Does a 70-year-old man … who spent decades criticizing vaccines and who’s financially vested in finding fault with vaccines, can he change his attitudes and approach now that he’ll have the most important position influencing vaccine policy in the United States?” Cassidy said. 

The hearing was the second in two days for Kennedy during which he squared off with Democrats and some Republicans over his past comments on vaccines, abortion and COVID-19 among other topics. 

The Finance Committee, which Kennedy appeared before on Wednesday, has not yet said if it will send Kennedy’s nomination to the full Republican-controlled Senate, which has not rejected any of Trump’s nominees so far. 

A spokesperson for the Finance Committee said a vote could potentially take place next week, but that one had not yet been scheduled.   

Cassidy, who sits on both committees, told Kennedy at the end of Thursday’s hearing that Kennedy would be hearing from him over the weekend, presumably regarding questions he has over the nomination.   

Kennedy’s nomination could fail to move to the Senate for consideration if all Democrats on the Finance Committee voted against him and were joined by Cassidy.   

During wide-ranging questioning on Thursday, Kennedy spoke more confidently than the day prior, adjusting the characterization of previous statements, and saying he would support the U.S. children’s vaccination schedule, research and development for bird flu, and scientific data on vaccine safety. 

Kennedy also said he would address rapidly increasing rates of chronic disease. 

“Our country is not going to be destroyed because we get the marginal tax rate wrong. It is going to be destroyed if we get this issue wrong,” he said of chronic diseases. “And I am in a unique position to be able to stop this epidemic.” 

He was asked about comments he has made over decades, including that it was “highly likely” that Lyme disease was a military bioweapon. He said he never said that it was definitively created in a biolab.   

He would not answer a question from Senator Bernie Sanders about whether he agreed that vaccines do not cause autism. He also said he did not know if the coronavirus vaccine saved millions of lives. 

“If you come out unequivocally, ‘vaccines are safe, it does not cause autism’ that would have an incredible impact,” Cassidy said.   

Kennedy has said vaccines are linked to autism, and he opposed state and federal restrictions imposed during the COVID-19 pandemic. The causes of autism are unclear, though theories that childhood vaccines cause autism have been widely debunked and are contrary to scientific evidence.   

Kennedy, who founded the anti-vaccine group Children’s Health Defense, argued during both hearings that he was not against vaccines. The group has sued in state and federal courts over vaccines. 

“News reports and many in the hearing yesterday have claimed that I’m anti-vaccine and anti-industry. Well, I’m neither,” Kennedy said, repeating that his children are vaccinated.   

Thursday’s hearing in front of the Senate Committee on Health, Education, Labor and Pensions is a courtesy hearing with no vote involved. However, Republican Senators Cassidy, Lisa Murkowski and Susan Collins sit on the committee, all of whom are seen as potential swing votes against Kennedy. 

Supporters of Kennedy wearing “Make America Healthy Again” hats crowded around the committee hearing room on Thursday, while some opposing his confirmation wore “Reject RFK Jr” stickers on their shirts. 

‘Catastrophic’ impacts   

If confirmed, Kennedy would run HHS, which oversees more than $3 trillion in healthcare spending, including at the Food and Drug Administration and the agency in charge of the Medicare and Medicaid health insurance programs covering nearly half of all Americans.   

He said he would follow Trump’s direction on abortion and would hire for his department those who are against abortion rights.   

Kennedy also said gender-affirming care for children has “catastrophic” impacts and that children are not equipped to make judgments about receiving such care. He said he would rescind a Biden-era rule that requires medical providers who receive federal funding to offer gender-affirming care.   

Kennedy said farmers should be offered an off-ramp from chemically intensive agriculture, and that illness in farm communities is “undoubtedly” related to the use of pesticides. Some farm and food groups have expressed concern about Kennedy’s positions on pesticides and food additives.   

Opposition groups have ramped up their efforts to persuade Republican senators to vote against Kennedy. Caroline Kennedy, another member of the storied American political family, on Tuesday urged senators to vote against her cousin’s nomination, calling him a predator with dangerous views on health care. 

Kennedy has also faced scrutiny over his ties to Wisner Baum, a law firm specializing in pharmaceutical drug injury cases. He has an arrangement to earn 10% of fees awarded in contingency cases he refers to the firm, according to a letter Kennedy wrote to an HHS ethics official released last week. 

If confirmed, Kennedy would retain that financial interest in cases that do not directly impact the U.S. government, the letter said.   

If his nomination goes to the full Senate, Kennedy would need the support of at least 50 senators, which would allow Vice President JD Vance to cast another tie-breaking vote to confirm his nomination. 

Uganda confirms Ebola outbreak in capital Kampala, one dead

Kampala, Uganda — Uganda has confirmed an outbreak of Ebola virus disease in the capital Kampala, with the first confirmed patient dying from the disease on Wednesday, the health ministry said on Thursday.

The patient, a nurse at the Mulago referral hospital in the capital, had initially sought treatment at various facilities, including Mulago after developing fever-like symptoms.

“The patient experienced multi-organ failure and succumbed to the illness at Mulago National Referral Hospital on Jan 29. Post-mortem samples confirmed Sudan Ebola Virus Disease (strain),” the ministry said.

The highly infectious hemorrhagic fever is transmitted through contact with infected bodily fluids and tissue. Symptoms include headache, vomiting blood, muscle pains and bleeding.

Uganda last suffered an outbreak in late 2022 and that outbreak was declared over on Jan. 11, 2023, after nearly four months in which it struggled to contain the viral infection.

The last outbreak killed 55 of the 143 people infected and the dead included six health workers.

Trump Health and Human Services nominee defends past statements about vaccines, COVID, health care

Robert F. Kennedy Jr., President Donald Trump’s nominee to serve as the nation’s top health official, faced tough questions from senators Wednesday about his views on vaccinations, COVID-19 and the nation’s health care system. A member of one of America’s most famous political families, Kennedy could face a tough road to confirmation. VOA’s Congressional Correspondent Katherine Gypson has more.

WHO warns polio progress in Afghanistan, Pakistan at risk due to US funding cut

ISLAMABAD — A senior World Health Organization official cautioned Wednesday that the eradication of polio in Afghanistan and Pakistan, the only countries where the paralytic virus persists, is threatened by the suspension of funding from the United States.

In an online news conference, Hanan Balkhy, regional director for the Eastern Mediterranean, emphasized the crucial role of U.S. financial contribution to the organization’s surveillance efforts for polio and all other communicable diseases, particularly within her region.

Last week, U.S. President Donald Trump ordered an unprecedented 90-day suspension of almost all foreign aid to give his administration the time to evaluate whether to continue funding the numerous humanitarian, development and security programs that receive U.S. assistance.

On his first day back in the White House, Trump announced he was withdrawing the United States from WHO.

His executive order accused the United Nations agency of mishandling the COVID-19 pandemic and other global health crises, as well as failing “to adopt urgently needed reforms, and its inability to demonstrate independence from the inappropriate political influence of WHO member states.”

Balkhy referred to Trump’s announcement to withdraw from WHO as “very unfortunate” and highlighted that the U.S. has been a “major” supporter of her organization’s work in the Eastern Mediterranean region for decades.

“The U.S. funding was indeed decisive in fighting polio, eradicating polio. Currently, we are in the last round of eradicating polio in the last two countries in the world: Afghanistan and Pakistan,” the Saudi physician said through an interpreter.

“We hope that our collaboration with our partners will enable us to achieve our goal of fully eradicating polio in these countries during this final stage,” she added.

Balkhy emphasized WHO’s dedication to safeguarding the world against the resurgence of polio.

In 2024, Pakistan reported 73 cases of the paralytic poliovirus, while Afghanistan reported 25 cases. Although there have been no additional polio cases in Afghanistan so far, Pakistani officials confirmed the first poliovirus infection of 2025 last week.

Balkhy attributed efforts led by WHO to contain what she described as the “inevitable” spread of polio in Gaza due to the destruction of its sewage and sanitation services.

She stated they are prepared to discuss the reforms the United States plans to propose and carry out necessary internal assessments to help advance the organization’s work.

“Funding shortfalls in 2024 have already led to devastating cuts to lifesaving health operations. We ask for your support in amplifying our message — help us save lives, restore health systems and bring hope to millions,” Balkhy said.

Russia weds biolab, organ harvesting conspiracies to discredit US, Ukraine

Russian disinformation narratives about illicit organ harvesting and biological experiments in Ukraine have no basis in fact. Russia intentionally distorts Ukrainian law intended to support vital medical procedures.   

CIA: COVID likely originated in a lab, but agency has ‘low confidence’ in report

WASHINGTON — The CIA now believes the virus responsible for the COVID-19 pandemic most likely originated from a laboratory, according to an assessment released Saturday that points the finger at China even while acknowledging that the spy agency has “low confidence” in its own conclusion.

The finding is not the result of any new intelligence, and the report was completed at the behest of the Biden administration and former CIA Director William Burns. It was declassified and released Saturday on the orders of President Donald Trump’s pick to lead the agency, John Ratcliffe, who was sworn in Thursday as director.

The nuanced finding suggests the agency believes the totality of evidence makes a lab origin more likely than a natural origin. But the agency’s assessment assigns a low degree of confidence to this conclusion, suggesting the evidence is deficient, inconclusive or contradictory.

Earlier reports on the origins of COVID-19 have split over whether the coronavirus emerged from a Chinese lab, potentially by mistake, or whether it arose naturally. The new assessment is not likely to settle the debate. In fact, intelligence officials say it may never be resolved, due to a lack of cooperation from Chinese authorities.

The CIA “continues to assess that both research-related and natural origin scenarios of the COVID-19 pandemic remain plausible,” the agency wrote in a statement about its new assessment.

Instead of new evidence, the conclusion was based on fresh analyses of intelligence about the spread of the virus, its scientific properties and the work and conditions of China’s virology labs.

Lawmakers have pressured America’s spy agencies for more information about the origins of the virus, which led to lockdowns, economic upheaval and millions of deaths. It’s a question with significant domestic and geopolitical implications as the world continues to grapple with the pandemic’s legacy.

Republican Sen. Tom Cotton of Arkansas, chairman of the Senate Intelligence Committee, said Saturday he was “pleased the CIA concluded in the final days of the Biden administration that the lab-leak theory is the most plausible explanation,” and he commended Ratcliffe for declassifying the assessment.

“Now, the most important thing is to make China pay for unleashing a plague on the world,” Cotton said in a statement.

China’s embassy in Washington did not immediately return messages seeking comment. Chinese authorities have in the past dismissed speculation about COVID’s origins as unhelpful and motivated by politics.

While the origin of the virus remains unknown, scientists think the most likely hypothesis is that it circulated in bats, like many coronaviruses, before infecting another species, probably racoon dogs, civet cats or bamboo rats. In turn, the infection spread to humans handling or butchering those animals at a market in Wuhan, where the first human cases appeared in late November 2019.

Some official investigations, however, have raised the question of whether the virus escaped from a lab in Wuhan. Two years ago, a report by the Energy Department concluded a lab leak was the most likely origin, though that report also expressed low confidence in the finding.

The same year then-FBI Director Christopher Wray said his agency believed the virus “most likely” spread after escaping from a lab.

Ratcliffe, who served as director of national intelligence during Trump’s first term, has said he favors the lab leak scenario, too.

“The lab leak is the only theory supported by science, intelligence, and common sense,” Ratcliffe said in 2023.

The CIA said it will continue to evaluate any new information that could change its assessment.

Namibia doctors fight cervical cancer

WINDHOEK, NAMIBIA — The cervical cancer rate in Namibia is 37.5 for every 100,000 women, about three times higher than the rate worldwide.  Cervical cancer is one of the most preventable cancers and doctors in Namibia are advocating greater access to healthcare and the HPV vaccine to reduce the prevalence of the disease. 

November 2009 was a turning point in the life of Barbara Kamba-Nyathi. At the tender age of 29, she was diagnosed with stage three cervical cancer.  

Her doctors recommended radiation therapy as opposed to chemotherapy, because at that time she had not yet had children and radiation therapy would help her avoid premature menopause.

But that was not her only struggle. Kamba-Nyathi, who lived in Windhoek at the time, said she faced stigma for cervical cancer’s association with HIV and the human papilloma virus.  

“One of the challenges that come with having a diagnosis like cervical cancer is that our African society its usually taboo to talk about things of our reproductive organs, you know, our reproductive system is taboo,” said Kamba-Nyathi. “We don’t talk about such things and in the end, we tend to normalize pain and even things that don’t feel right in our bodies we tend to normalize them and they become part of our identity.” 

Rolf Hansen, the chief executive officer of the Cancer Association of Namibia, said a lack of education and a lack of access to healthcare prevent many women from getting tested or being treated for cervical cancer or HPV, which is the second-leading cause of cancer among sub-Saharan women. 

“Like I said, HIV and HPV work hand in hand to fuel the cervical cancer pandemic,” said Hansen. “Now, in our country as well we see that in our low-income setting as well as our rural setting, we have high HPV prevalence, high cervical cancer so a lot of work needs to be done at a grassroots level so that we can actually combat this disease.” 

Doctors Simon and David Emvula provide health services to underprivileged communities, together with the Be Free/Break Free program — an initiative of former first lady Monica Geingos — in Namibia’s largest township of Katutura. They are advocating for the rollout of the HPV vaccine for girls between the ages of 9 and 14, before they become sexually active. 

Emvula said that during one screening in Windhoek on Saturday, they treated more than 100 patients, screening girls and women for HPV, cervical cancer, fibroids and other sexually transmitted infections  and sexually transmitted diseases.  

Emvula spoke to VOA at his practice in Windhoek. 

“The turnout was actually beyond what we expected and once again it was an eye-opener … that there is definitely a need for that,” said Emvula. 

Emvula said HPV vaccination is among the most effective ways to prevent cervical cancer but the government of Namibia is lagging. 

HPV vaccines have been introduced in 129 countries worldwide and the Namibian government has endorsed the rollout of the vaccines for girls ages 9 to 14. Despite promises made as reported by VOA last year, the vaccines have not yet been made available. 

Namibia’s executive director of health, Ben Nangombe, could not be reached for comment.

Bird migrations shifting with warming planet in US Southwest

In the Southwest United States, bird migrations are shifting as global temperatures warm. Gustavo Martіnez Contreras takes us to the Bosque del Apache National Wildlife Refuge in the state of New Mexico.

California marine sanctuary protects waters from oil drilling

After President Joe Biden announced a ban on oil and gas drilling off most of the U.S. coastline in early January, President-elect Donald Trump quickly vowed to reverse it after he takes office on January 20. But there is one section of the California coast that has gained more permanent protection from drilling – a new national marine sanctuary. Genia Dulot takes us underwater for a look.

Proposed rules would require nutrition info, allergen warnings on US alcohol labels 

Labels on wine, distilled spirits and malt beverages in the U.S. would be required to list alcohol content and nutritional information per serving, plus notification of potential allergens, under two new rules proposed Thursday by the Treasury Department. 

The department’s Alcohol and Tobacco Tax and Trade Bureau is seeking public content on proposals to require an “alcohol facts” box — similar to nutrition labels on food — that would list alcohol content, calories, carbohydrates, fat and protein per serving. A second rule would require labels to declare top allergens, including milk, eggs, fish, shellfish, tree nuts, wheat, peanuts, soybean and sesame. 

The changes are consistent with the bureau’s mandate “to ensure that labels provide consumers with adequate information about the identity, quality and alcohol content of alcohol beverages,” according to a notice published in the Federal Register. 

Similar rules were first proposed nearly two decades ago and later championed in petitions submitted by advocacy groups, including the Center for Science in the Public Interest. 

“The proposals represent a momentous step toward ensuring consumers have access to the information they need to make informed choices, follow health guidelines and avoid allergic reactions,” CSPI officials said in a statement. 

Companies have been allowed to provide the information voluntarily for several years. In August 2021, a survey from the Beer Institute indicated that 95% of beer volume sold by several top producers contained nutrition information provided voluntarily, the bureau noted. Advocates, however, maintained that a limited number of companies used voluntary labels, “underscoring the need for a mandatory policy.” 

The Wine Institute, a trade group, said it would support digital labels that contained the required information. “Given the unique nature of winemaking, the most accurate and least burdensome approach to providing nutrition information to consumers would be to allow the option of off-label disclosure via QR code or other electronic means,” the group said. 

The Distilled Spirits Council of the United States also suggested QR codes or website references. 

Comments will be accepted through April 16. The rules would take effect five years from the date of final approval. 

The move is the second major change for alcohol labels announced in the waning days of the Biden administration. On Jan. 5, U.S. Surgeon General Vivek Murthy called for new warnings about the link between alcohol and cancer. 

The new proposals come as the government is updating dietary guidelines, including those around alcohol, that will form the cornerstone of federal food programs and policy. The updated guidelines are expected later this year. 

The current guidelines recommend women have one drink or fewer per day while men should stick to two or fewer.

Malawi takes steps to end cholera outbreaks by 2030

BLANTYRE, MALAWI — Malawi’s government launched a plan Thursday to stop cholera outbreaks by 2030.

Officials say that if the government and international partners can effectively cooperate, they can greatly reduce the prevalence of cholera in the southern African country, where it has killed at least 1,700 people over the past three years.

Partners include the World Health Organization, or WHO, and UNICEF.

Minister of Health Khumbize Kandodo-Chiponda said, “The goal of the plan is to reduce the annual cholera rate by 90% and achieve the case fatality rate of less than 1% by the year 2030, as recommended by WHO.”

Kandodo-Chiponda said there are several ways to achieve the goal, all of which involve the government, development partners, civil society organizations and other stakeholders supplying expertise and funding to support prevention and control efforts.

She said those efforts will be “to increase access to safe water and sanitation facilities and promote improved hygiene practices; to raise awareness and promote community-led initiatives to prevent and to respond to outbreaks.”

Malawi has experienced cholera outbreaks over the past three years, with the most severe occurring in 2022, resulting in over 1,700 deaths nationwide.

During Thursday’s event, the Malawian government launched an oral cholera vaccine campaign targeting four districts — Mzimba, Karonga, Balaka and Machinga — to address a recent resurgence of cholera there.

Statistics from the Presidential Task Force on Cholera show the disease has caused 14 deaths since September.

Shadrack Omol, UNICEF’s representative in Malawi, said the 2024 resurgence of cholera shows that root causes of the infectious bacterial disease persist.

“Health interventions … are complimentary in support,” Omol said. “The key to addressing the root causes is in provision of safe drinking water across our country, improving sanitation and improving hygiene practices.”

Malawi’s public health experts say goals to eradicate the disease within five years will depend on stakeholder commitments.

George Jobe, executive director of the Malawi Health Equity Network, said, “If financial investments [and] technical investments from partners are done, we believe we can win this battle. It should not be a document that should grow dust on the shelves.”

Kandodo-Chiponda said the operational plans will be reviewed at least once every year to keep ahead of any possible cholera outbreaks.

SpaceX catches Starship booster again, but upper stage explodes

WASHINGTON — Hours after Jeff Bezos’s Blue Origin nailed its first-ever orbital mission, SpaceX seized back the spotlight on Thursday as its latest test of Starship, its gargantuan next-generation mega rocket, ended with the upper stage dramatically disintegrating over the Atlantic.

In terms of sheer excitement, Elon Musk’s company didn’t disappoint, underscoring its technical prowess by catching the first stage booster in the “chopstick” arms of its launch tower for a second time.

But the triumph was short-lived when teams lost contact with the upper stage vehicle. SpaceX later confirmed it had undergone “rapid unscheduled disassembly,” the company’s euphemism for an explosion.

A taller, improved version of the biggest and most powerful launch vehicle ever built blasted off from the company’s Starbase in Boca Chica, Texas, at 4:37 p.m. (2237 GMT) for its seventh test.

The gleaming prototype rocket is key to Musk’s ambitions of colonizing Mars, while NASA hopes to use a modified version as a human lunar lander.

Around seven minutes after liftoff, the Super Heavy booster decelerated from supersonic speeds — generating sonic booms — before descending gracefully into the launch tower’s waiting arms, prompting an eruption of applause from ground control teams.

The maneuver was first successfully executed in October, but not November, when Super Heavy made a controlled splashdown in the Gulf of Mexico instead.

Soon after the latest booster catch, however, announcers on a live webcast confirmed the upper stage vehicle had been lost following a propulsion anomaly.

The FlightAware tracker showed several planes in the Atlantic altering course near the Turks and Caicos Islands, while users on X shared dramatic footage purportedly capturing the spaceship breaking apart in a fiery cascade during atmospheric reentry.

“Success is uncertain, but entertainment is guaranteed!” Musk wrote on X, sharing one of the clips. He added the cause of the explosion appeared to be an “oxygen/fuel leak” and that the company would take corrective steps.

A Federal Aviation Administration (FAA) spokesperson said the agency “briefly slowed and diverted aircraft around the area where space vehicle debris was falling.”

Well wishes

Ahead of the SpaceX launch, Blue Origin’s massive New Glenn rocket reached orbital space for the first time, marking a potential turning point in the commercial space race.

SpaceX has long dominated orbital launches with its Falcon 9 rocket, securing contracts from private companies, the Pentagon and NASA.

In contrast, Blue Origin had been limited to short hop suborbital flights with its smaller New Shepard rocket — but could now look to erode SpaceX’s market share.

Although the two tech titans have had a contentious past, Musk congratulated Bezos “on reaching orbit on the first attempt,” and Bezos returned the goodwill a few hours later.

“Good luck today @elonmusk and the whole spacex team!!” the Amazon founder wrote on X.

NASA’s outgoing chief Bill Nelson meanwhile offered his congratulations to SpaceX for the booster catch, adding: “Spaceflight is not easy.”

For this flight, SpaceX announced it had made numerous upgrades, and increased Starship’s size to 123 meters tall. New Glenn stands 98 meters tall.

While its Falcon rockets remain steadfast workhorses, SpaceX has made clear it sees Starship as its future.

The first three test flights ended in dramatic explosions, resulting in the loss of vehicles. However, SpaceX has rapidly iterated on its design, reflecting its “fail fast, learn fast” philosophy.

Musk is now aiming to drastically ramp up the frequency of tests, requesting permission from the FAA to carry out 25 in 2025, compared to just four in 2024.

The agency is holding public meetings on potential environmental and regulatory concerns, amid accusations that SpaceX has harmed ecologically sensitive areas and violated wastewater regulations.

But with Musk now part of Trump’s inner circle, the billionaire may find a smoother path under the incoming administration.

Meanwhile, Bezos and fellow tech mogul Mark Zuckerberg are set to attend the president-elect’s inauguration on Monday, signaling warming ties.

US CDC recommends faster testing for bird flu in hospitalized patients

People hospitalized for flu should be tested for bird flu within 24 hours, the U.S. Centers for Disease Control and Prevention said on Thursday, in an expansion of the agency’s efforts to tackle increasing infections in humans. 

The advisory is intended to prevent delays in identifying human cases of avian influenza A (H5N1) viruses amid high levels of seasonal influenza. 

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, the agency said. 

Still, influenza A-positive patients, particularly those in an intensive care unit, should be tested ideally within 24 hours of hospitalization to identify the viral subtype and determine whether they have bird flu, the agency said. 

Prior to Thursday’s guidance, hospitals generally sent batches of samples to labs for subtyping every few days. 

Faster testing also aims to help doctors identify how people became infected and provide their close contacts with testing and medicine more quickly, if needed, said Nirav Shah, the agency’s principal deputy director, on a call with reporters. 

The CDC does not believe it has been missing bird flu infections in people, Shah said. No surveillance system detects 100% of cases, he added later. 

“The system is working as it should,” said Shah, adding that health officials want results sooner in case any public health action is needed. “What we need is to shift to a system that tells us what’s happening in the moment.” 

Nearly 70 people in the United States, most of them farmworkers, have contracted bird flu since April, as the virus has circulated among poultry flocks and dairy herds. Three people have tested positive without a clear source of exposure to the virus, according to CDC. 

Most infections in humans have been mild, but one fatality was reported in Louisiana last week. 

The U.S. Department of Agriculture has more than 300 personnel working on its bird flu response and has spent $1.5 billion on its efforts to curb the spread among poultry and dairy cattle, said Eric Deeble, a deputy undersecretary at the agency. 

The USDA last week said it would rebuild a bird flu vaccine stockpile for poultry. 

USDA officials have met several times with the transition team of the incoming Donald Trump administration to try to ensure a smooth handoff on agency actions to curb the spread of the virus, including a tabletop exercise at the White House on Wednesday, Deeble said. 

Officials at the Department of Health and Human Services, which encompasses CDC, also have repeatedly met with the transition team on Zoom calls and have shared their bird flu playbook, officials said on the press call.  

HHS said on Thursday it plans to put $211 million toward mRNA-based vaccine technology to better respond to emerging infectious diseases such as bird flu.  

WHO appeals for $1.5 billion to tackle ‘unprecedented’ global health crisis

GENEVA — The World Health Organization appealed Thursday for $1.5 billion for emergency operations this year, warning that conflict, climate change, epidemics and displacement had converged to create an “unprecedented global health crisis.”

The U.N. health agency estimated that health crises would leave 305 million people in need of urgent humanitarian assistance this year.

“WHO is seeking $1.5 billion to support our lifesaving work for the emergencies we know about and to react swiftly to new crises,” WHO chief Tedros Adhanom Ghebreyesus said as he launched the appeal.

The agency’s emergency request, which was for the same amount as last year’s request, outlined the critical priorities and resources needed to address 42 ongoing health emergencies.

“Conflicts, outbreaks, climate-related disasters and other health emergencies are no longer isolated or occasional — they are relentless, overlapping and intensifying,” Tedros said in a statement.

He pointed to the emergency health assistance provided in conflict zones ranging from the occupied Palestinian territories to the Democratic Republic of Congo to Sudan, as well as its work conducting vaccination campaigns, treating malnutrition and helping control outbreaks of diseases like cholera.

“Without adequate and sustainable funding, we face the impossible task of deciding who will receive care and who will not this year,” Tedros said at Thursday’s event.

“Your support helps to ensure that WHO remains a lifeline, bridging the gap between sickness and health, despair and hope, life and death for millions of people worldwide.”